1. Home
  2. Compare CGM systems

Compare CGM systems
and see the difference

CGM = continuous glucose monitoring

The FreeStyle Libre family of products are the #1 CGM’s prescribed in the US*

  • More affordable, at 1/2 the cost of other CGM systems†1

  • Small, discreet‡1-3, and no overpatch required for regular sensor use

  • Provides readings every minute4,5

FSL Family Product
FSL Family Product
FSL Family Product

See how the features of the FreeStyle Libre 2 and FreeStyle Libre 3 Systems compare

test

Features

test
sensor-size
Sensor size

 

Smaller than two stacked pennies1

 

Same thickness as two stacked quarters

application
Application

 

Easy to apply1 using a 1-piece applicator
(no in-person patient training required)1

 

Easy to apply (no in-person patient training
required)1

cost
Cost

 

Less than $40 per month for most covered
patients§1

 

Less than $40 per month for most covered
patientsǁ1

Sensor lifespan

 

14 days

 

14 days

Glucose reading

 

Every 1 minute5 (by streaming)

 

 

Every 1 minute4 (by scanning)

 

Alarms/Alerts

 

Most are optional

 

Most are optional#

App

 

FreeStyle Libre 3 app**

 

 

FreeStyle Libre 2 app**

 

Sensor memory storage

 

14 days5

 

 

8 hours4

 

Sensor warm-up time

 

1 hour

 

 

1 hour

 

Calibration

 

Not required5

 

Not required4

Indication

Indicated for:

  • Management of diabetes in persons ages

    4 and older

  • Use by women with diabetes who are

    pregnant

Indicated for:

  • Management of diabetes in persons ages

    4 and older

  • Use by women with diabetes who are

    pregnant

 

FreeStyle Libre 2 and FreeStyle Libre 3 systems are indicated for use in people with diabetes ages 4 and older.

Abbott provides this information as a courtesy, it is subject to change and interpretation. The customer is ultimately responsible for determining the appropriate codes, coverage, and payment policies for individual patients. Abbott does not guarantee third party coverage or payment for our products or reimburse customers for claims that are denied by third party payors.

Medicare coverage is available for FreeStyle Libre systems if their respective readers are used to review glucose data on some days every month. Medicare and other third-party payor criteria apply.

* Data based on the number of patients assigned to each manufacturer based on last filled prescription in US Retail Pharmacy and DME.

† Based on a comparison of list prices of the FreeStyle Libre personal CGM systems versus competitors’ CGM systems, assuming annual use of one receiver (or equivalent hardware) and quantity of transmitters and/or sensors according to use life. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.

‡ Data from these studies were collected with the outside US version of FreeStyle Libre 14 day system. FreeStyle Libre 2 has the same features as FreeStyle Libre 14 day system with optional, real-time glucose alarms. Therefore, the study data is applicable to both products.

§ Based on prescription claims for commercially insured patients using the FreeStyle Libre personal CGM systems. Does not include Medicare, Medicaid, uninsured, and other federal or state healthcare program patients. The actual amount a patient pays may vary. The FreeStyle Libre 3 system requires a prescription.

ǁ Based on prescription claims for commercially insured patients using the FreeStyle Libre 2 system. Does not include Medicare, Medicaid, uninsured, and other federal or state healthcare program patients. The actual amount a patient pays may vary. The FreeStyle Libre 2 system requires a prescription.

¶ Notifications will only be received when alarms are turned on and the sensor is within 33 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 3 User’s Manual for more information.

# Notifications will only be received when alarms are turned on and the sensor is within 20 feet unobstructed of the reading device. You must enable the appropriate settings on your smartphone to receive alarms and alerts, see the FreeStyle Libre 2 User’s Manual for more information.

** The FreeStyle Libre 2 or 3 apps are only compatible with certain mobile devices and operating systems. Please check our compatibility guide for more information about device compatibility before using the apps. Use of the apps may require registration with LibreView.


References: 1.
Data on File. Abbott Diabetes Care. 2. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-treated Type 2 Diabetes: a Multicentre, Open-label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (2017): 55-73. https://doi.org/10.1007/s13300-016-0223-6. 3. Campbell, Fiona M., et al. "Outcomes of Using Flash Glucose Monitoring technology by Children and young people with Type 1 Diabetes in a Single Arm Study." Pediatric Diabetes 19, no. 7 (2018): 1294-1301. https://doi.org/10.1111/pedi.12735. 4. FreeStyle Libre 2 User's Manual. 5. FreeStyle Libre 3 User's Manual.

ADC-74100 v1.0

Important Safety Information

FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855‑632‑8658 or FreeStyleLibre.us for safety info.

The product images are for illustrative purposes only.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.

No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United States.

ADC-45115 v19.0